119 related articles for article (PubMed ID: 15684608)
1. Alterations of p53 and Bcl-2 protein expression in the laryngeal intraepithelial neoplasia.
Hussein MR
Cancer Biol Ther; 2005 Feb; 4(2):213-7. PubMed ID: 15684608
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia.
Mahomed A; Chetty R
Arch Ophthalmol; 2002 May; 120(5):554-8. PubMed ID: 12003603
[TBL] [Abstract][Full Text] [Related]
3. Correlation of tumor markers p53, bcl-2 and cathepsin-D with clinicopathologic features and disease-free survival in laryngeal squamous cell carcinoma.
Lazaris AC; Lendari I; Kavantzas N; Kandiloros D; Adamopoulos G; Davaris P
Pathol Int; 2000 Sep; 50(9):717-24. PubMed ID: 11012985
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
5. [The protein expression of p53 and bcl-2 in laryngeal squamous cell carcinoma].
Liu S; Tang S; Lin Y; Liang C
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):191-3. PubMed ID: 12600081
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma.
Klatka J
Eur Arch Otorhinolaryngol; 2001 Dec; 258(10):537-41. PubMed ID: 11829192
[TBL] [Abstract][Full Text] [Related]
8. [Expression of survivin and its correlation with p53 and bcl-2 expression in laryngeal and hypopharyngeal cancer].
Sun M; Qin Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Apr; 22(8):346-8, 351. PubMed ID: 18595518
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
10. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
11. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.
Izawa H; Yonemitsu N; Shin T; Sugihara H
Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma.
Friedman M; Lim JW; Manders E; Schaffner AD; Kirshenbaum GL; Tanyeri HM; Caldarelli DD; Coon JS
Head Neck; 2001 Apr; 23(4):280-5. PubMed ID: 11400228
[TBL] [Abstract][Full Text] [Related]
13. Regulators of proliferation and apoptosis in carcinoma of the larynx.
Whisler LC; Wood NB; Caldarelli DD; Hutchinson JC; Panje WR; Friedman M; Preisler HD; Leurgans S; Nowak J; Coon JS
Laryngoscope; 1998 May; 108(5):630-8. PubMed ID: 9591537
[TBL] [Abstract][Full Text] [Related]
14. Analysis of hMSH2 mismatch repair protein expression in dysplasia, carcinoma in situ and invasive squamous cell carcinoma of the vocal folds.
Hussein MR; Aref EE; Yassen DG; Ramadan MO
Cancer Invest; 2009 Jan; 27(1):38-46. PubMed ID: 19160096
[TBL] [Abstract][Full Text] [Related]
15. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
17. Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the upper Egypt.
Hussein MR; Ismael HH
Cancer Biol Ther; 2004 Oct; 3(10):983-8. PubMed ID: 15467428
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous-cell carcinoma.
Pruneri G; Pignataro L; Carboni N; Ronchetti D; Cesana BM; Ottaviani A; Neri A; Buffa R
Int J Cancer; 1998 Jun; 79(3):263-8. PubMed ID: 9645348
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
